{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T04:37:48Z","timestamp":1648787868322},"reference-count":20,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,21]],"date-time":"2013-07-21T00:00:00Z","timestamp":1374364800000},"content-version":"vor","delay-in-days":2819,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Therapeutic Research"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1016\/j.curtheres.2005.12.006","type":"journal-article","created":{"date-parts":[[2006,2,24]],"date-time":"2006-02-24T12:20:44Z","timestamp":1140783644000},"page":"501-510","source":"Crossref","is-referenced-by-count":1,"title":["Tolerability and feasibility of eptifibatide in acute coronary syndrome in patients at high risk for cardiovascular disease: A retrospective analysis"],"prefix":"10.1016","volume":"66","author":[{"given":"Zaher S.","family":"Azzam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elias","family":"Sa'ad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amal","family":"Jabareen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oron","family":"Eilam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petru","family":"Bartha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salim","family":"Hadad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norberto","family":"Krivoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.curtheres.2005.12.006_bib1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1056\/NEJM200001133420207","article-title":"Unstable angina pectoris","volume":"342","author":"Yeghiazarians","year":"2000","journal-title":"N Engl J Med."},{"key":"10.1016\/j.curtheres.2005.12.006_bib2","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(00)05060-1","article-title":"Effect of glycoprotein IIb\/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: The GUSTO IV-ACS randomised trial","volume":"357","author":"Simoons","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.curtheres.2005.12.006_bib3","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1056\/NEJM199805213382102","article-title":"Inhibition of the platelet glycoprotein IIb\/IIIa receptor with tirofiban in unstable angina and non-Qwave myocardial infarction","volume":"338","author":"Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators","year":"1998","journal-title":"N Engl J Med."},{"key":"10.1016\/j.curtheres.2005.12.006_bib4","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1056\/NEJM199805213382103","article-title":"A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina","volume":"338","author":"Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study Investigators","year":"1998","journal-title":"N Engl J Med."},{"key":"10.1016\/j.curtheres.2005.12.006_bib5","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJM199808133390704","article-title":"Inhibition of platelet glycoprotein IIb\/IIIa with eptifibatide in patients with acute coronary syndromes. Platelet Glycoprotein IIb\/IIIa in Unstable Angina: Receptor suppression using integrilin therapy","volume":"339","author":"The PURSUIT Trial Investigators","year":"1998","journal-title":"N Engl J Med."},{"key":"10.1016\/j.curtheres.2005.12.006_bib6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0140-6736(02)07442-1","article-title":"Platelet glycoprotein IIb\/IIIa inhibitors in acute coronary syndromes: A meta-analysis of all major randomised clinical trials","volume":"359","author":"Boersma","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.curtheres.2005.12.006_bib7","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1161\/01.CIR.100.20.2045","article-title":"Platelet glycoprotein IIb\/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: Early benefit during medical treatment only, with additional protection during percutaneous coronary intervention","volume":"100","author":"Boersma","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.curtheres.2005.12.006_bib8","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0002-8703(99)70075-X","article-title":"Development of eptifibatide","volume":"138","author":"Scarborough","year":"1999","journal-title":"Am Heart J."},{"key":"10.1016\/j.curtheres.2005.12.006_bib9","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S0002-8703(03)00165-0","article-title":"Combining enoxaparin and glycoprotein IIb\/IIIa antagonists for the treatment of acute coronary syndromes: Final results of the National Investigators Collaborating on Enoxaparin-3 (NICE-3) study","volume":"146","author":"Ferguson","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.curtheres.2005.12.006_bib10","first-page":"136","article-title":"Low-molecular-weight heparins and glycoprotein IIb\/IIIa antagonists in acute coronary syndromes","volume":"16","author":"Ferguson","year":"2004","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.curtheres.2005.12.006_bib11","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0002-9149(02)02652-8","article-title":"Safety and effectiveness of combined low molecular weight heparin and glycoprotein IIb\/IIIa inhibitors","volume":"90","author":"Kovar","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.curtheres.2005.12.006_bib12","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1161\/01.CIR.101.22.2557","article-title":"Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients","volume":"101","author":"Boersma","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.curtheres.2005.12.006_bib13","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1001\/jama.284.7.835","article-title":"The TIMI risk score for unstable angina\/nonST elevation MI: A method for prognostication and therapeutic decision making","volume":"284","author":"Antman","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.curtheres.2005.12.006_bib14","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/S0735-1097(02)02336-7","volume":"40","author":"Braunwald","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.curtheres.2005.12.006_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0735-1097(88)90158-1","article-title":"Thrombolysis in Myocardial Infarction (TIMI) Trialphase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase","volume":"11","author":"Rao","year":"1988","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.curtheres.2005.12.006_bib16","series-title":"Nominal dependent variables","first-page":"167","year":"1992"},{"key":"10.1016\/j.curtheres.2005.12.006_bib17","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0735-1097(02)02631-1","article-title":"Safety of concomitant therapy with eptifibatide and enoxaparin in patients undergoing percutaneous coronary interven tion: Results of the Coronary Revascularization Using Integrilin and Single bolus Enoxaparin Study","volume":"41","author":"Bhatt","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.curtheres.2005.12.006_bib18","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.2165\/00003495-200262120-00005","article-title":"Combination of low molecular weight heparins with antiplatelet agents in non-ST elevation acute coronary syndromes: An update","volume":"62","author":"Cohen","year":"2002","journal-title":"Drugs"},{"key":"10.1016\/j.curtheres.2005.12.006_bib19","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1161\/01.CIR.0000050144.67910.13","article-title":"Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb\/IIIa inhibitor eptifibatide","volume":"107","author":"Goodman","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.curtheres.2005.12.006_bib20","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0002-8703(03)00509-X","article-title":"Global patterns of use of antithrombotic and antiplatelet therapies in patients with acute coronary syndromes: Insights from the Global Registry of Acute Coronary Events (GRACE)","volume":"146","author":"Budaj","year":"2003","journal-title":"Am Heart J"}],"container-title":["Current Therapeutic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X05001256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X05001256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T08:29:21Z","timestamp":1547800161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011393X05001256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S0011393X05001256"],"URL":"https:\/\/doi.org\/10.1016\/j.curtheres.2005.12.006","relation":{},"ISSN":["0011-393X"],"issn-type":[{"value":"0011-393X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}